Full video transcriptClick to expand
Auto-generated transcript of @gustavodaplug's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Guys today is going to be day one of TRT testosterone replacement therapy.
- 0:06Dr. Jack Montesage from, I know it's like 3.26 or something, but I take a couple different
- 0:13medications so they said that could have brought it down.
- 0:15It has a little how to use, how to inject, and then you can see here it's prescribed with a 0.5
- 0:25once every seven days.
- 0:27So it looks like I'm going to be injecting once every seven days today.
- 0:33I'm going to do it right now.
- 0:47One two peers, they just go to the right room.
- 0:53That's it.
- 0:55I guess that's it.
- 0:58Oh, just follow me if you want to see what the updates are.
- 1:02We're going to see how this goes.
TRT day-one claims: what the science actually supports
Quick answer
The creator reports initiating weekly injectable testosterone therapy with a prescription-level testosterone reading that, if expressed in nmol/L at 3.26, would represent severe hypogonadism meeting standard clinical thresholds. His mention of concurrent medications suppressing testosterone is clinically plausible and consistent with secondary hypogonadism. The stated dose of 0.5mg is inconsistent with standard testosterone injectable formulations and likely reflects a unit misreading of his prescription label.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For TRT day-one claims: what the science actually supports, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
TRT day-one claims: what the science actually supports is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "TRT day-one claims: what the science actually supports" from LuisGustavo. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator reports initiating weekly injectable testosterone therapy with a prescription-level testosterone reading that, if expressed in nmol/L at 3.
The reason this review is not generic is the source wording and the canonical claim label "trt day 1 on trt i just started testosterone replacement therapy." In this clip, the useful excerpt is: "Guys today is going to be day one of TRT testosterone replacement therapy." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The creator reports initiating weekly injectable testosterone therapy with a prescription-level testosterone reading that, if expressed in nmol/L at 3.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator reports initiating weekly injectable testosterone therapy with a prescription-level testosterone reading that, if expressed in nmol/L at 3.26, would represent severe hypogonadism meeting standard clinical thresholds. His mention of concurrent medications suppressing testosterone is clinically plausible and consistent with secondary hypogonadism. The stated dose of 0.5mg is inconsistent with standard testosterone injectable formulations and likely reflects a unit misreading of his prescription label.
- The AUA defines low testosterone as below 300 ng/dL; the Endocrine Society recommends two separate morning blood draws before diagnosis, not a single result.
- A stated dose of 0.5mg injectable testosterone is almost certainly a unit misreading. Standard therapeutic doses of testosterone cypionate range from 50 to 200mg per week.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- The AUA defines low testosterone as below 300 ng/dL; the Endocrine Society recommends two separate morning blood draws before diagnosis, not a single result.
- A stated dose of 0.5mg injectable testosterone is almost certainly a unit misreading. Standard therapeutic doses of testosterone cypionate range from 50 to 200mg per week.
- A lab value of 3.26 is uninterpretable without units. In nmol/L it converts to roughly 94 ng/dL, which is clinically low; in ng/dL it is not a valid lab result.
- Medications including opioids, corticosteroids, and some antidepressants can suppress testosterone levels by acting on the hypothalamic-pituitary-gonadal axis (Rajagopal et al., 2004).
- A 2023 NEJM trial (Lincoff et al.) found a statistically significant increase in non-fatal cardiovascular events with testosterone therapy in higher-risk men, a risk the creator does not mention.
- TRT suppresses the body's own testosterone production and can reduce sperm count, making fertility counseling an important part of pre-treatment conversations for men who may want children.
- Snyder et al. (2016) found TRT improved sexual function and bone density in older hypogonadal men but showed more modest effects on energy and mood, which are often overclaimed in social media content.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @gustavodaplug actually say?
He said he's starting testosterone replacement therapy with a prescription for "0.5 once every seven days" as an injection, and that his testosterone level is "3.26 or something." He also mentioned he takes other medications and was told those "could have brought it down." That's the core of what we have to work with. There's no lab context, no unit clarification, no mention of symptoms beyond what the caption lists.
To his credit, he's not selling anything here. He's documenting a personal medical experience that appears to involve an actual prescription from a named provider. That's a meaningfully different category of TRT content than the usual "I crushed a vial of test and got jacked" posts that flood this platform.
Does the science back this up?
The short answer: it depends entirely on what "3.26" means. If that's nanomoles per liter, it falls below the clinical threshold most endocrinologists use. If it's nanograms per deciliter, that number doesn't exist on a standard lab panel and something is off with the reporting.
Most U.S. labs report total testosterone in ng/dL. The American Urological Association defines low testosterone as below 300 ng/dL, and the Endocrine Society's 2018 clinical practice guidelines (Bhasin et al., Journal of Clinical Endocrinology and Metabolism) set the diagnostic threshold between 264 and 300 ng/dL depending on the assay. A reading of 3.26 in those units is not physiologically possible. If the lab used nmol/L, which is standard in Canada and parts of Europe, 3.26 nmol/L converts to roughly 94 ng/dL, which is genuinely low and would meet most clinical criteria for hypogonadism.
His claim that other medications "could have brought it down" is also plausible. Opioids, glucocorticoids, certain antidepressants, and antipsychotics are all documented to suppress the hypothalamic-pituitary-gonadal axis (Rajagopal et al., 2004, Journal of Pain and Symptom Management).
What did they get wrong (or right)?
The dosing language is where things get murky. "0.5mg" is not a standard way to prescribe injectable testosterone. Testosterone cypionate and enanthate are typically dosed in milligrams but prescribed by volume, and standard starting doses are usually in the 50-100mg range per week, not 0.5mg. Either he's misreading the prescription label, the dose is written in milliliters rather than milligrams and he's conflating the two, or something else is going on with the formulation.
This matters. If a viewer hears "0.5mg of testosterone" and takes that as a reference dose, they are receiving incorrect information. The actual therapeutic dose of testosterone cypionate is roughly 100 to 200 times higher than what he stated, depending on the patient. He may simply be misreading his syringe or prescription label, but he's presenting it confidently on a public platform.
What he got right: starting slow under physician guidance, documenting the process transparently, and not making any outrageous claims about what TRT will do for him. That restraint is worth acknowledging.
What should you actually know?
TRT is a legitimate, FDA-approved treatment for hypogonadism, but "low T" as a diagnosis requires more than a single blood test. The Endocrine Society recommends at least two separate morning testosterone measurements before initiating therapy, along with assessment of luteinizing hormone and follicle-stimulating hormone to determine whether the problem originates in the testes or the pituitary. A single number of "3.26" with no further context is not a complete diagnostic picture.
Injectable testosterone carries real risks that don't get enough airtime in this kind of content: erythrocytosis (elevated red blood cell count), suppression of endogenous testosterone production, potential effects on fertility, and cardiovascular considerations that researchers are still actively debating (Lincoff et al., 2023, New England Journal of Medicine, found a modest increase in cardiovascular events in some higher-risk populations). None of this means TRT is dangerous across the board, but starting without understanding these trade-offs is a problem.
If you're considering TRT because a video made it look easy, the right first step is a comprehensive hormone panel, not a syringe.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
LuisGustavo · TikTok creator
2.3K views on this video
Day 1 on TRT 🚨 | I just started testosterone replacement therapy (TRT) 0.5mg injection to begin. TRT is used to treat low testosterone levels, which can affect energy, mood, libido, focus, muscle growth & more. Low T can happen due to aging, stress, or underlying conditions. I’ll be documenting my journey physical, mental, emotional changes. 🧠💪
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about the aua defines low testosterone as below 300 ng/dl; the?
The AUA defines low testosterone as below 300 ng/dL; the Endocrine Society recommends two separate morning blood draws before diagnosis, not a single result.
What does the video say about a stated dose of 0.5mg injectable testosterone?
A stated dose of 0.5mg injectable testosterone is almost certainly a unit misreading. Standard therapeutic doses of testosterone cypionate range from 50 to 200mg per week.
What does the video say about a lab value of 3.26?
A lab value of 3.26 is uninterpretable without units. In nmol/L it converts to roughly 94 ng/dL, which is clinically low; in ng/dL it is not a valid lab result.
What does the video say about medications including opioids, corticosteroids,?
Medications including opioids, corticosteroids, and some antidepressants can suppress testosterone levels by acting on the hypothalamic-pituitary-gonadal axis (Rajagopal et al., 2004).
What does the video say about a 2023 nejm trial (lincoff et al.) found a statistically?
A 2023 NEJM trial (Lincoff et al.) found a statistically significant increase in non-fatal cardiovascular events with testosterone therapy in higher-risk men, a risk the creator does not mention.
What does the video say about trt suppresses the body's own testosterone production?
TRT suppresses the body's own testosterone production and can reduce sperm count, making fertility counseling an important part of pre-treatment conversations for men who may want children.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Not medical advice. This video was made by LuisGustavo, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.